SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-024221
Filing Date
2023-07-11
Accepted
2023-07-11 16:05:34
Documents
24
Period of Report
2023-07-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46373
2 ex5-1.htm EX-5.1 32873
3 ex5-1_001.jpg GRAPHIC 3087
4 ex5-1_002.jpg GRAPHIC 5407
5 ex5-2.htm EX-5.2 33518
6 ex5-2_001.jpg GRAPHIC 7457
7 ex5-2_002.jpg GRAPHIC 9246
8 ex5-3.htm EX-5.3 18534
9 ex5-3_001.jpg GRAPHIC 2864
10 ex5-3_002.jpg GRAPHIC 1327
11 ex5-4.htm EX-5.4 18605
12 ex5-4_001.jpg GRAPHIC 2865
13 ex5-4_002.jpg GRAPHIC 1327
  Complete submission text file 0001493152-23-024221.txt   390611

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE vbiv-20230711.xsd EX-101.SCH 3024
15 XBRL LABEL FILE vbiv-20230711_lab.xml EX-101.LAB 34240
16 XBRL PRESENTATION FILE vbiv-20230711_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3261
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 231082220
SIC: 2834 Pharmaceutical Preparations